RNTX

Conviction 0HealthcareScan · Mon, Aug 10, 2026

RNTX$0.7936-2.92%

ResistanceSupportVol 14

Vol MA14 462.17K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Rein Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.reintx.com ↗

Price0.7936

Change-2.92%

Gap-1.66%

Rel volume0.50×

Avg volume432.5K

Avg $ vol346.87K

SMA 200.8103

SMA 500.9095

SMA 2001.22

Price vs 50-12.74%

Price vs 200-34.87%

MA stackbearish

50/200 cross—

Supertrenddown · 0.9616

RSI (14)44

MACD hist0.01

MACD crossbull · 1d

Stoch %K / %D43 / 45

ADX (14)23

+DI / −DI13 / 18

RSI divergenceBullish

MACD divergence—

ATR %+9.26%

ADR %8.95%

52w high1.88

52w low0.7144

From 52w high-57.79%

Above 52w low+11.09%

New 52w highNo

SqueezeOff

Bollinger width29.71%

%B0.43

Donchian pos37.47%

Donchian high0.9598

Donchian low0.6940

AVWAP (52w high)1.38

vs AVWAP high-42.37%

AVWAP (52w low)0.7544

vs AVWAP low+5.20%

OBV trendDown

Chaikin MF (20)-0.15

Today vs 20d0.50×

Avg vol (14d)462.17K

Avg vol (20d)432.5K

Avg $ vol (20d)346.87K

Market cap67.88M

RS 3m (vs SPY)-35.83%

RS 6m (vs SPY)-42.40%

RS line new highNo

Trend template0/8

Technical rank14.3

1 week+6.45%

1 month-19.02%

3 months-34.95%

6 months-30.39%

1 year-28.50%

YTD-36.51%

P/E-1.36

P/B5.86

P/S—

P/FCF-3.48

EPS-1.96

Div yield—

ROE-430.26%

ROA-189.71%

Debt/Eq—

Current0.40

EV/EBITDA-1.25

Gross margin—

Net margin—

Rev growth—

EPS growth20.69%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value63.44M

Revenue0

Net income-5.84M

Gross profit—

Free cash flow-19.52M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out85.54M

Employees10

ListedThu, Jun 29, 2017

Free float22.5M

Float %85.6%

Short interest878.62K

Days to cover2.5d

Short volume60.0%

Squeeze score34 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank14.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.05

Support0.7129

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RNTX

All disclosures →

No recent disclosed trades by Congress in RNTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RNTX

No recent insider (Form 4) filings in RNTX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in RNTX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.